Apollomics (APLM) Invested Capital (2021 - 2023)
Apollomics (APLM) posted quarterly Invested Capital of $6.2 million for Q4 2023, up 133.7% year-over-year from $2.7 million in Q4 2022, and up 133.7% quarter-over-quarter from $2.7 million in Q4 2022.
Apollomics (APLM) Invested Capital (2021 - 2023) Analysis & Trends
Apollomics (APLM) has reported Invested Capital for 3 consecutive years, with $6.2 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Invested Capital rose 133.7% year-over-year to $6.2 million; the TTM figure through Dec 2025 stood at $8.9 million (changed N/A YoY), while the FY2023 annual figure was $6.2 million, up 133.7% from the prior year.
- Invested Capital rose to $6.2 million in Q4 2023 per APLM's latest filing, from $2.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $6.2 million in Q4 2023 and bottomed at $95524.0 in Q2 2022.
- Historically, Invested Capital has averaged $2.5 million across 3 years, with a median of $1.9 million in 2021.
- Annual changes were most pronounced in 2022 — Invested Capital jumped 151.8% — and 2023, when it jumped 133.7%.
- Apollomics' Invested Capital stood at $1.1 million in 2021, then surged by 151.8% to $2.7 million in 2022, then surged by 133.7% to $6.2 million in 2023.
- Business Quant data shows APLM's Invested Capital at $6.2 million in Q4 2023, $2.7 million in Q4 2022, and $95524.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Apollomics | 35.18 Mn | 31.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 6.21 Mn |
| Dec 31, 2022 | 2.66 Mn |
| Jun 30, 2022 | 95,524.00 |
| Dec 31, 2021 | 1.06 Mn |